Literature DB >> 26663970

An interesting case of Coats' disease.

Avinash Mishra1, Somesh Aggarwal2, Sonali Shah2, Puja Negi3, Rekha Bharwada4, Neha Desai2.   

Abstract

Entities:  

Keywords:  Coats' disease; Intra-vitreal anti-vascular endothelial growth factor; Intra-vitreal long acting steroids; Laser photocoagulation

Year:  2014        PMID： 26663970      PMCID： PMC4646943          DOI： 10.1016/j.mjafi.2013.11.010

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN： 0377-1237


× No keyword cloud information.
  14 in total

1.  Clinical-pathologic correlation in Coats' disease.

Authors:  J B Jonas; L M Holbach
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2001-07       Impact factor: 3.117

2.  A combination of intravitreal bevacizumab injection with tunable argon yellow laser photocoagulation as a treatment for adult-onset Coats' disease.

Authors:  Kai-Yun Wang; Cheng-Kuo Cheng
Journal:  J Ocul Pharmacol Ther       Date:  2011-09-27       Impact factor: 2.671

3.  Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction.

Authors:  Aparna Ramasubramanian; Carol L Shields
Journal:  Br J Ophthalmol       Date:  2011-06-07       Impact factor: 4.638

4.  Intravitreal anti-vascular endothelial growth factor agents as an adjunct in the management of Coats' disease in children.

Authors:  Shalini Kaul; Mahesh Uparkar; Kruti Mody; Jaydeep Walinjkar; Mihir Kothari; S Natarajan
Journal:  Indian J Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 1.848

5.  The effect of intravitreal bevacizumab in the treatment of Coats disease in children.

Authors:  Chun-Ju Lin; Jiunn-Feng Hwang; Yan-Ting Chen; San-Ni Chen
Journal:  Retina       Date:  2010-04       Impact factor: 4.256

6.  A population-based study of Coats disease in the United Kingdom I: epidemiology and clinical features at diagnosis.

Authors:  B Morris; B Foot; A Mulvihill
Journal:  Eye (Lond)       Date:  2010-09-24       Impact factor: 3.775

7.  Classification and management of Coats disease: the 2000 Proctor Lecture.

Authors:  J A Shields; C L Shields; S G Honavar; H Demirci; J Cater
Journal:  Am J Ophthalmol       Date:  2001-05       Impact factor: 5.258

8.  Clinical variations and complications of Coats disease in 150 cases: the 2000 Sanford Gifford Memorial Lecture.

Authors:  J A Shields; C L Shields; S G Honavar; H Demirci
Journal:  Am J Ophthalmol       Date:  2001-05       Impact factor: 5.258

9.  Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.

Authors:  Christos Haritoglou; Daniel Kook; Aljoscha Neubauer; Armin Wolf; Siegfried Priglinger; Rupert Strauss; Arnd Gandorfer; Michael Ulbig; Anselm Kampik
Journal:  Retina       Date:  2006 Nov-Dec       Impact factor: 4.256

10.  Elevated vascular endothelial growth factor levels in Coats disease: rapid response to pegaptanib sodium.

Authors:  Young Sun; Atul Jain; Darius M Moshfeghi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-03-07       Impact factor: 3.117
View more
  1 in total

1.  Longitudinal characterization and treatment response of retinal arterial macroaneurysms in adult-onset coats disease.

Authors:  Amisha D Dave; Alisa T Thavikulwat; Tharindu De Silva; Henry E Wiley; Tiarnan D L Keenan; Wai T Wong; Catherine A Cukras
Journal:  Am J Ophthalmol Case Rep       Date:  2022-07-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.